Results 191 to 200 of about 114,562 (319)

The tumor-associated fibroblasts regulate urothelial carcinoma progression. [PDF]

J Mol Cell Biol
Xiao Y, Yang J, Sun M, Li Y, Liu Q, Leng J, Yang M, Wang J, Li H, Yang C, Luo C, Li J, Kang L, Huang F, Yu Y, Zhang C.   +15 more
europepmc   +1 more source

The Homeobox Genes: Classification, Regulation, Biological Functions, and Diseases

MedComm, Volume 7, Issue 4, April 2026.
Overview of the homeobox gene superfamily and its pathophysiological roles. The homeobox superfamily comprises several major classes, including ANTP, PRD, TALE, LIM, POU, and others. Among these, the HOX clusters (A–D) play critical roles in embryonic development specifically in conferring cellular identity, regulating morphogenesis, and guiding axial ...
Maedeh Dadzadi, Shahin Ramazi, Mona Darvazi, Sepideh Yoosefi, Melika Abbasi, Shirin Farsad   +5 more
wiley   +1 more source

Case Report: Whole-genome sequencing of urothelial carcinoma in an adult patient with CLOVES syndrome reveals a lack of <i>PIK3CA</i> mutation and a genomic landscape consistent with urothelial carcinoma. [PDF]

Front Oncol
McAuley L, Fitzpatrick O, Cosgrove N, Yacoub J, Grogan L, Hennessy BT, Furney SJ, Toomey S.   +7 more
europepmc   +1 more source

Antibody–Drug Conjugates in Oncology: Principles, Clinical Development, and Future Directions

MedComm, Volume 7, Issue 4, April 2026.
Antibody–drug conjugates integrate antibody targeting with potent cytotoxic payloads to enable precision cancer therapy. Their clinical performance depends on coordinated optimization of engineering design, tumor antigen biology, and treatment strategy. Lessons from uro‐oncological malignancies illustrate how ADCs can be effectively developed, combined,
Bisheng Cheng, Lanqi Gong, Zongwei Wang, Peidan Peng, Kewei Xu, Hai Huang, Peng Wu   +6 more
wiley   +1 more source

High-Grade Urothelial Carcinoma Arising From a Ureteral Diverticulum: A Rare Case Report. [PDF]

IJU Case Rep
Papadopoulos I, Ledderose S, Ebner B, Berg E, Aydogdu C, Marcon J, Bischoff R, Kazmierczak P, Stief CG, Eismann L.   +9 more
europepmc   +1 more source

Chromosome 1 Open Reading Frame 35 Drives Colorectal Cancer Progression by Enhancing Tumor‐Intrinsic Proliferation and CD8+ T Cell Suppression

MedComm, Volume 7, Issue 4, April 2026.
This study identifies C1orf35 as a key driver of colorectal cancer progression through a dual mechanism. It promotes tumor‐intrinsic cell proliferation and migration via the c‐Myc/PYCR2 axis, and suppresses anti‐tumor immunity by impairing CD8+ T‐cell immune surveillance, nominating it as a novel therapeutic target in colorectal cancer.
Shaosen Zhang, Changjiang Yang, Xunye Xu, Lan Lan, Ziyi He, Jiaoting Chen, Caihong Wang   +6 more
wiley   +1 more source

Complete Response to Pembrolizumab After Progression on Avelumab Maintenance in Metastatic Urothelial Carcinoma. [PDF]

IJU Case Rep
Ito F, Kobayashi K, Hayashi G, Kamijo S, Fujita T.   +4 more
europepmc   +1 more source

Exploring the role of YES1 kinase in regulating cisplatin resistance through iTRAQ-based quantitative proteomic analysis in urothelial carcinoma

Chia‐Che Wu
openalex   +1 more source

Labels, Language and Other Strategies to Improve Communication About Lowest Grade Ductal Carcinoma in Situ: Qualitative Interviews With Women and Physicians

Psycho-Oncology, Volume 35, Issue 4, April 2026.
ABSTRACT Objective Women diagnosed with ductal carcinoma in situ (DCIS) and clinicians have reported challenges in communication about DCIS, contributing to women's confusion and anxiety. This study explored how to improve communication about DCIS including alternative labels, language and other strategies.
Suzanna Apostolovski, Nicole J. Look Hong, Frances C. Wright, Anna R. Gagliardi   +3 more
wiley   +1 more source

Early Recognition of Immune-Related Hepatitis During Avelumab Maintenance Therapy for Urothelial Carcinoma. [PDF]

IJU Case Rep
Iwama Y, Sano T, Sano Y, Kimura T, Naito Y, Inoue S, Matsuo K, Ishida S, Matsukawa Y, Akamatsu S.   +9 more
europepmc   +1 more source